E2.1 RA Drugs Flashcards
Name drugs for treating RA
- are NSAIDS a good drug for treating RA
Disease modifying anti-rheumatic drugs (DMARDs) such as
Glucocorticoids
Conventional synthetic DMARDs (classical)
Biological DMARDs (anti-TNF etc.)
Targeted synthetic DMARDs (JAK inhibitors)
- good drug choice for treating pain in RA however they don’t alter disease progression….
What factors dictate what combinations of drugs are used to treat RA
Disease progression (severity and rate of joint damage),
How well the patient responds to a chosen DMARD,
Patient becomes refractory to a DMARD,
Other underlying health conditions and the severity of side effects.
The cost of treatment
- Name some DMARS
- Describe efficacy in trials
- Describe drug onset
- infliximab, cyclosporin, sulphasalazine, leflunomide, methotrexate, corticosteroids and IL-1 receptor antagonists
- These were all superior to placebo in reducing erosions in RA
Anti-malarials appear to be less effective - The drugs are slow in onset and NSAIDs are needed to control pain
GC suppress what actions of inflammatory response
All actions
Reduce vascular permeability
Inhibit adhesion molecule expression
- (required to get WBC into inflamed joint
Inhibit fibroblast activity
- slow fibroblast proliferation/ release of MMP
Inhibit WBC accumulation/activity
Inhibit COX-2 and cytokine production (e.g. Il-1, IL-6)
Used less frequently due to side effects
Describe mechanism of action of GC
Act intracellularly to modify transcription either by
1. induction
2. Repression
(therefore induce anti-inflammatory molecules or inhibit production of pro-inflam molecules)
Increasing interest in non-genomic effects mediated by membrane-bound receptors (e.g. immunosuppression of T-cells)
What does annexin-1 do to PG pathway?
nnexin inhibits PG pathway - direct PLE2 directly turns off prostaglandin and leukotriene production downstream
Inhibits neutrophil accumulation
- involved acute inflammation
Inhibits monocyte-macrophage accumulation
Inhibits macrophage phagocytosis
Inhibits production of cytokines by macrophages
[All beneficial results]
Glucocorticoids inhibit synthesis of what inflammatory mediators
GENE REPRESSION - due to GC binding arachidonic acid metabolites NO (via iNOS) inflammatory cytokines (e.g. TNFα, IL-1, IL-8, IL-12) Chemokines (CXCL) adhesion molecules
Adverse effects of glucocorticoids
Glucocorticoids have severe significant side effects which prohibit long-term use
- Used short term at low dose
Multi-systemic metabolic effects, such as –
GI tract bleeding
Osteoporosis
Ulcer formation